Skip to main content
Clinical Trials/CTRI/2025/03/081623
CTRI/2025/03/081623Not yet recruitingNot Applicable

Effectiveness of individualized homoeopathic medicine in treatment of pain & stiffness of lumbar spondylosis in post menopausal women an open label pre and post interventional clinical study

Self Dr Mousumi Roy1 site in 1 country40 target enrollmentStarted: March 14, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
To measure difference in mean Oswestry low back pain disability quistionnarire score.

Study Overview

Brief Summary

Research Question whether individualized homoeopathic medicine can produce change in pain and stiffness in lumbar  spondylosis among the post menopausal women Null hypothesis there is no significant difference in mean Oswestry Low Back Pain Disability Questionnaire score before and after giving Homoeopathic Individualized medicine for 6 months selected by individualization in case of lumbar spondylosis among post menopausal women Alternative Hypothesis there is significant difference in mean Oswestry Low Back Pain Disability Questionaarie score before and after giving Homoeopathic Individualized medicine for 6 months selected by individualization in cases of lumbar spondylosis among post menopausal women Aim to evaluate the effectiveness of Homoeopathic Individualized medicine in the treatment of pain and stiffness of lumbar spondylosis among post menopausal women Objectives to ascertain the change in Oswestry Low Back Pain Disability Questionnarire score before and after medical intervention via individualized medicine

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
45.00 Year(s) to 60.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1 Patient presenting with clinical features and radiological findings of lumbar spondylosis 2 Female gender with both acute and chronic complains 3 all socio economical status 4 patient who are willing to give informed consent to participate in the study.

Exclusion Criteria

  • 1Case with congenital lumbar annomalies eg spina bifida 2Patient unwilling to give consent for taking part in the study and regular follow ups 3Patient with terminal or life threatening illness 4 Patient shifting from one system of medicine to another system of medicine frequently 5 Patient undergone lumbar spine surgery.

Outcomes

Primary Outcomes

To measure difference in mean Oswestry low back pain disability quistionnarire score.

Time Frame: baseline and after 6 months of treatment

Secondary Outcomes

  • not present

Investigators

Sponsor
Self Dr Mousumi Roy
Sponsor Class
Other [Self Dr Mousumi Roy]
Responsible Party
Principal Investigator
Principal Investigator

Dr Mousumi Roy

National Institute of Homoeopathy

Study Sites (1)

Loading locations...

Similar Trials